DE102022003441A1 - Omega3 and essential amino acid supplements - Google Patents
Omega3 and essential amino acid supplements Download PDFInfo
- Publication number
- DE102022003441A1 DE102022003441A1 DE102022003441.7A DE102022003441A DE102022003441A1 DE 102022003441 A1 DE102022003441 A1 DE 102022003441A1 DE 102022003441 A DE102022003441 A DE 102022003441A DE 102022003441 A1 DE102022003441 A1 DE 102022003441A1
- Authority
- DE
- Germany
- Prior art keywords
- omega
- fatty acids
- acids
- deficiency
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000020776 essential amino acid Nutrition 0.000 title abstract description 3
- 239000003797 essential amino acid Substances 0.000 title abstract description 3
- 239000013589 supplement Substances 0.000 title abstract description 3
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 12
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims abstract description 6
- 229940012843 omega-3 fatty acid Drugs 0.000 claims abstract description 6
- 239000006014 omega-3 oil Substances 0.000 claims abstract description 6
- 150000001413 amino acids Chemical class 0.000 claims abstract description 5
- 239000002253 acid Substances 0.000 abstract description 4
- 230000007812 deficiency Effects 0.000 abstract description 4
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 4
- 229930195729 fatty acid Natural products 0.000 abstract description 4
- 239000000194 fatty acid Substances 0.000 abstract description 4
- 150000004665 fatty acids Chemical class 0.000 abstract description 4
- 238000000554 physical therapy Methods 0.000 abstract description 4
- 230000008092 positive effect Effects 0.000 abstract description 4
- 208000025721 COVID-19 Diseases 0.000 abstract description 3
- 208000008425 Protein deficiency Diseases 0.000 abstract description 2
- 150000007513 acids Chemical class 0.000 abstract description 2
- 230000005800 cardiovascular problem Effects 0.000 abstract description 2
- 235000005911 diet Nutrition 0.000 abstract description 2
- 230000037213 diet Effects 0.000 abstract description 2
- 235000021323 fish oil Nutrition 0.000 abstract description 2
- 210000000987 immune system Anatomy 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 239000004006 olive oil Substances 0.000 abstract description 2
- 235000008390 olive oil Nutrition 0.000 abstract description 2
- 238000004806 packaging method and process Methods 0.000 abstract description 2
- 102000004169 proteins and genes Human genes 0.000 abstract description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract 2
- 235000004626 essential fatty acids Nutrition 0.000 abstract 2
- 208000023835 Tendon disease Diseases 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 235000021196 dietary intervention Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 abstract 1
- 239000000902 placebo Substances 0.000 abstract 1
- 229940068196 placebo Drugs 0.000 abstract 1
- 150000003180 prostaglandins Chemical class 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Bezeichnung: Zum Patent angemeldet werden soll eine Nahrungsergänzung bestehend aus einer oder mehreren essentiellen Aminosäuren in Verbindung mit Omega 3 FettsäureKurzfassung Problemstellung: Sowohl im Nahrungsergänzungsbereich als auch im medizinischen Bereich werden die Fettsäuren nicht näher differenziert. Auf den Verpackungen steht lediglich der Fettanteil allgemein. In unserer Ernährung und in den Nahrungsergänzungsmitteln finden sich in der Regel überwiegend Omega 6 Säuren in Verbindung mit Aminosäuren (Eiweiß). Im allgemeinen liegt ein relativer Omega 3 Säure Mangel vor, oft auch in Verbindung mit einem Eiweißmangel.Lösung des Problems: Die Schaffung einer Nahrungsergänzung bestehend aus Omega 3 und Aminosäure(n). Diese Kombination wirkt sich positiv auf das Gedächtnis; die Konzentration; Herz-Kreislauf Probleme und Depressionen aus. Ferner stärkt sie das Immunsystem.Kurzauswahl an Quellennachweisen/Studien:Folgende Studien beziehungsweise Arbeiten belegen den positiven Effekt, beziehungsweise weisen auf die Folgen eines Mangels hin:Messen, Analysieren, Regulieren Klinische Relevanz eines optimierten Fettsäurestatus durch natürliches Fischöl/Olivenölgemisch; Masterarbeit vorgelegt von Dr. Med. Jochen Henn Matrikelnummer 36145; Hauptstraße 21 83684 Tegernseer März 2014Blood omega 3 fatty acids and death from COVID-19: A pilot study;Arash Asher; Nathan I. Tintle; Michael Myers; Laura Lockshorn, Heribert Bacareza; Prostaglandines, Leukotriens and essential fatty acids 166 (2021)Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular outcomes; Annuals of internal medicine 6.8.2019;171 (3):190-198The effect of essential fatty acids and antioxidants combined with physiotherapy treatment in recreational athlete with chronic tendon disorders; Arandomised, double-blind, placebo controlled study ;Physical Therapy in Sport 5 /2004)194-199Anwendung: Das Nahrungsergänzungsmittel kann als tägliches Supplement angewendet werden.Name: A patent application is to be filed for a nutritional supplement consisting of one or more essential amino acids in combination with Omega 3 fatty acids. Summary of the problem: Both in the nutritional supplement sector and in the medical sector, the fatty acids are not further differentiated. The packaging simply states the general fat content. Our diet and dietary supplements usually contain predominantly omega 6 acids in combination with amino acids (protein). In general, there is a relative omega 3 acid deficiency, often in connection with a protein deficiency. Solution to the problem: The creation of a nutritional supplement consisting of omega 3 and amino acid(s). This combination has a positive effect on memory; the concentration; Cardiovascular problems and depression. It also strengthens the immune system. Short selection of sources/studies: The following studies or works prove the positive effect or point out the consequences of a deficiency: Measuring, analyzing, regulating Clinical relevance of an optimized fatty acid status through natural fish oil/olive oil mixture; Master's thesis presented by Dr. Med. Jochen Henn matriculation number 36145; Hauptstraße 21 83684 Tegernseer March 2014Blood omega 3 fatty acids and death from COVID-19: A pilot study;Arash Asher; Nathan I Tintle; Michael Myers; Laura Lockshorn, Heribert Bacareza; Prostaglandins, Leukotriens and essential fatty acids 166 (2021) Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular outcomes; Annuals of internal medicine 6.8.2019;171 (3):190-198The effect of essential fatty acids and antioxidants combined with physiotherapy treatment in recreational athlete with chronic tendon disorders; Arandomized, double-blind, placebo controlled study ;Physical Therapy in Sport 5 /2004)194-199Application: The dietary supplement can be used as a daily supplement.
Description
Bezeichnung: Zum Patent angemeldet werden soll eine Nahrungsergänzung bestehend aus einer oder mehreren essentiellen Aminosäuren in Verbindung mit Omega 3 FettsäureName: A patent application is to be filed for a nutritional supplement consisting of one or more essential amino acids in combination with Omega 3 fatty acids
Kurzfassung Problemstellung: Sowohl im Nahrungsergänzungsbereich als auch im medizinischen Bereich werden die Fettsäuren nicht näher differ enziert. Auf den Verpackungen steht lediglich der Fettanteil allgemein. In unserer Ernährung und in den Nahrungsergänzungsmitteln finden sich in der Regel überwiegend Omega 6 Säuren in Verbindung mit Aminosäuren (Eiweiß). Im allgemeinen liegt ein relativer Omega 3 Säure Mangel vor, oft auch in Verbindung mit einem Eiweißmangel.Summary of the problem: In both the nutritional supplement sector and the medical sector, fatty acids are not differentiated in more detail. The packaging simply states the general fat content. Our diet and dietary supplements usually contain predominantly omega 6 acids in combination with amino acids (protein). In general, there is a relative omega 3 acid deficiency, often in connection with a protein deficiency.
Lösung des Problems: Die Schaffung einer Nahrungsergänzung bestehend aus Omega 3 und Aminosäure(n). Diese Kombination wirkt sich positiv auf das Gedächtnis; die Konzentration; Herz-Kreislauf Probleme und Depressionen aus. Ferner stärkt sie das Immunsystem.Solution to the problem: The creation of a nutritional supplement consisting of Omega 3 and amino acid(s). This combination has a positive effect on memory; the concentration; Cardiovascular problems and depression. It also strengthens the immune system.
Kurzauswahl an Quellennachweisen/Studien:Short selection of sources/studies:
Folgende Studien beziehungsweise Arbeiten belegen den positiven Effekt, beziehungsweise weisen auf die Folgen eines Mangels hin:
- Messen, Analysieren, Regulieren Klinische Relevanz eines optimierten Fettsäurestatus durch natürliches Fischöl/Olivenölgemisch; Masterarbeit vorgelegt von Dr. Med. Jochen Henn Matrikelnummer 36145; Hauptstraße 21 83684 Tegernseer März 2014
- Blood omega 3 fatty acids and death from COVID-19: A pilot study;
- Arash Asher; Nathan I. Tintle; Michael Myers; Laura Lockshorn, Heribert Bacareza; Prostaglandines, Leukotriens and essential fatty acids 166 (2021)
- Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular outcomes; Annuals of internal medicine 6.8.2019; 171(3):190-198
- The effect of essential fatty acids and antioxidants combined with physiotherapy treatment in recreational athlete with chronic tendon disorders; Arandomised, double-blind, placebo controlled study ;
- Physical Therapy in Sport 5 /2004)194-199
- Measuring, analyzing, regulating Clinical relevance of an optimized fatty acid status through natural fish oil/olive oil mixture; Master's thesis presented by Dr. Med. Jochen Henn matriculation number 36145; Hauptstraße 21 83684 Tegernseer March 2014
- Blood omega 3 fatty acids and death from COVID-19: A pilot study;
- Arash Asher; Nathan I Tintle; Michael Myers; Laura Lockshorn, Heribert Bacareza; Prostaglandins, Leukotriens and essential fatty acids 166 (2021)
- Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular outcomes; Annuals of internal medicine August 6, 2019; 171(3):190-198
- The effect of essential fatty acids and antioxidants combined with physiotherapy treatment in recreational athlete with chronic tendon disorders; Arandomised, double-blind, placebo-controlled study;
- Physical Therapy in Sport 5 /2004)194-199
Anwendung: Das Nahrungsergänzungsmittel kann als tägliches Supplement angewendet werden.Application: The dietary supplement can be used as a daily supplement.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102022003441.7A DE102022003441A1 (en) | 2022-09-17 | 2022-09-17 | Omega3 and essential amino acid supplements |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102022003441.7A DE102022003441A1 (en) | 2022-09-17 | 2022-09-17 | Omega3 and essential amino acid supplements |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE102022003441A1 true DE102022003441A1 (en) | 2024-03-28 |
Family
ID=90140213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE102022003441.7A Pending DE102022003441A1 (en) | 2022-09-17 | 2022-09-17 | Omega3 and essential amino acid supplements |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE102022003441A1 (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3907649A1 (en) | 1988-03-09 | 1989-09-28 | Biorex Kft | DRUGS, SUITABLE FOR VIRUS CONTROL AND IMMUNOSTIMULATION |
| DE69409969T2 (en) | 1993-12-14 | 1998-12-10 | Prospa B.V., Hoofddorp | MULTIPLE UNSATURATED FATTY ACID SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| WO2001010424A2 (en) | 1999-08-05 | 2001-02-15 | Basf Aktiengesellschaft | Reducing cholesterol oxides using n-3-pufa and vitamin e |
| EP2705844A1 (en) | 2011-04-13 | 2014-03-12 | Ajinomoto Co., Inc. | Nutritional composition |
| EP3744323A1 (en) | 2018-01-26 | 2020-12-02 | Ajinomoto Co., Inc. | Composition for preventing or improving nociceptive pain |
| WO2021151199A1 (en) | 2020-01-30 | 2021-08-05 | Silicycle Inc. | Process for preparing a solid form of basic amino acid salts of polyunsaturated fatty acids |
| WO2021151201A1 (en) | 2020-01-30 | 2021-08-05 | Silicycle Inc. | Process for manufacturing solid neutral amino acid salts of polyunsaturated fatty acids |
-
2022
- 2022-09-17 DE DE102022003441.7A patent/DE102022003441A1/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3907649A1 (en) | 1988-03-09 | 1989-09-28 | Biorex Kft | DRUGS, SUITABLE FOR VIRUS CONTROL AND IMMUNOSTIMULATION |
| DE69409969T2 (en) | 1993-12-14 | 1998-12-10 | Prospa B.V., Hoofddorp | MULTIPLE UNSATURATED FATTY ACID SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| WO2001010424A2 (en) | 1999-08-05 | 2001-02-15 | Basf Aktiengesellschaft | Reducing cholesterol oxides using n-3-pufa and vitamin e |
| EP2705844A1 (en) | 2011-04-13 | 2014-03-12 | Ajinomoto Co., Inc. | Nutritional composition |
| EP3744323A1 (en) | 2018-01-26 | 2020-12-02 | Ajinomoto Co., Inc. | Composition for preventing or improving nociceptive pain |
| WO2021151199A1 (en) | 2020-01-30 | 2021-08-05 | Silicycle Inc. | Process for preparing a solid form of basic amino acid salts of polyunsaturated fatty acids |
| WO2021151201A1 (en) | 2020-01-30 | 2021-08-05 | Silicycle Inc. | Process for manufacturing solid neutral amino acid salts of polyunsaturated fatty acids |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dighriri et al. | Effects of omega-3 polyunsaturated fatty acids on brain functions: a systematic review | |
| Kenny et al. | Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men | |
| Hussein | Cell membrane fatty acids and health | |
| Barlow et al. | Nutritional recommendations for n-3 polyunsaturated fatty acids and the challenge to the food industry | |
| Kiso | Pharmacology in health foods: effects of arachidonic acid and docosahexaenoic acid on the age-related decline in brain and cardiovascular system function | |
| CN106535919A (en) | Brain function improving agent, and prophylactic or therapeutic agent for cognitive dysfunction | |
| Chaves et al. | High omega-6/omega-3 fatty acid ratio diets and risk of noncommunicable diseases: is the tissue, the main issue? | |
| Karalis et al. | L-Carnitine as a diet supplement in patients with type II diabetes | |
| Don et al. | COHERENCE OF THE DEVELOPMENT OF ATHEROSCLEROSIS AND ETHNIC FOOD TRADITIONS OF THE WORLD REVIEW | |
| DE102022003441A1 (en) | Omega3 and essential amino acid supplements | |
| US20100255126A1 (en) | Medicament for treatment of cancer and other diseases | |
| KR20030028328A (en) | Ginseng food for strengthening study efficacy and the preparing method | |
| Augustin et al. | Coronary heart disease: dietary approaches to reducing risks | |
| Mironenko et al. | Vitamin F–description, effect on the body, best sources | |
| Houston | The Treatment of Hypertension With Nutrition, Nutritional Supplements, and Lifestyle | |
| Oguwike et al. | Evaluation of efficacy of walnut (Juglans Nigra) on blood pressure, haematological and biochemical profile of hypertensive subjects | |
| Amoh-Mensah et al. | Prevention of Hypertension: A critical review of the Health benefits of Salt, Garlic, Fish oil, Chocolate and Vitamin D | |
| Mascolo et al. | Nutritional value of fish species | |
| Mburu | The role of chia seeds oil in human health: A critical review | |
| Kartikey et al. | Effects of oxidative stress on development of osteoporosis, carcinogenesis, atherosclerosis and brain degeneration | |
| Mora et al. | Budwig diet | |
| CODREANU et al. | The Role of Pharmaconutrition in the Management of Arterial Hypertension | |
| Akrami et al. | Effects of Flaxseed Oil Consumption on Anthropometric Parameters in the Patients with Metabolic Syndrome: A Randomized Clinical Trial | |
| HOUSTON | 2828 The Treatment of Hypertension With Nutrition, Nutritional Supplements, and Lifestyle | |
| Naji et al. | Investigating the effect of using chitosan nanoparticles containing garlic in improvement of blood function in anemic male rats |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R012 | Request for examination validly filed | ||
| R016 | Response to examination communication |